Clinical Presentation and Outcomes of Opioid-Induced Adrenal Insufficiency
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Opioid-induced adrenal insufficiency (OIAI) may develop in patients treated with chronic opioids due suppression of the hypothalamic-pituitary-adrenal axis. Our objective was to describe clinical manifestations, biochemical presentation and clinical course of OIAI. METHODS: A retrospective study of adults diagnosed with OIAI between 2006 and 2018 at an academic center. Opioid daily dose was converted into morphine mg equivalent (MME). RESULTS: Forty patients (n=29, 73% women) taking chronic opioids at a daily median MME dose of 105 (60-200) mg and median duration of 60 (3-360) months were diagnosed with OIAI. Patients reported fatigue (n=29, 73%), musculoskeletal pain (n=21, 53%), and weight loss (n=17, 53%) for a median of 12 (1-132) months prior to diagnosis and only 7.5% (n=3) patients were identified with OIAI through case detection. Biochemical diagnosis of OIAI was based on 1) low morning cortisol, baseline ACTH and/or DHEAS in 59% (n=26) patients or 2) abnormal cosyntropin stimulation test (CST) in 41% (n=14) patients. With glucocorticoid replacement, 16/23 (70%) patients with available follow up experienced improvement in symptoms. Opioids were tapered or discontinued in 15 patients, of whom 10 were followed for adrenal function of which 7 (70%) recovered from OIAI. CONCLUSION: Minimum daily MME in patients diagnosed with OIAI was 60 mg/day. OIAI causes significant morbidity and recognition requires a high level of clinical suspicion. Appropriate glucocorticoid treatment led to improvement of symptoms in 70%. Resolution of OIAI occurred following opioid cessation or reduction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“opioids (due to HPA axis suppression) (46, 47)”
From The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System (2022) · cites this paper as [46]
In the citing paper
“Despite the millions of people worldwide using oral and transdermal opioids, the number of those diagnosed with opioidinduced secondary adrenal insufficiency is low, and there have been only very few published cases of adrenal crisis (112, 119, 122).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [119]
In the citing paper
“As well as common symptoms of cortisol deficiency, such as fatigue, nausea/vomiting, musculoskeletal pain, weight loss, headache, and light-headedness (119), less common but well recognized manifestations, such as hypercalcemia (123) and hypoglycemia (124) have been described.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [119]
In the citing paper
“Because this was an uncontrolled study and these symptoms/signs are common in patients on opioids with normal adrenal function, it is not possible to definitively attribute any clinical improvement to the glucocorticoid replacement.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [119]
In the citing paper
“The closest was fatigue, where 14 of 29 patients reported subjective improvement.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [119]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016
Dahlhamer, J., Lucas, J., Zelaya, Nahin, R., Mackey, S., DeBar, L., Kerns, R., Von Korff, M., Porter, L., & Helmick, C. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6736a2 · Cited by 2,598
Trends in long‐term opioid therapy for chronic non‐cancer pain
Boudreau, D., Von Korff, M., Rutter, C. M., Saunders, K., Ray, G. T., Sullivan, M. D., Campbell, C. I., Merrill, J. O., Silverberg, M. J., Banta‐Green, C., et al. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1833 · Cited by 522
Critical issues on opioids in chronic non-cancer pain:
Eriksen, J., Sjøgren, P., Bruera, E., Ekholm, O., & Rasmussen, N. K. (2006) · Pain · doi:10.1016/j.pain.2006.06.009 · Cited by 515
Endocrine consequences of long-term intrathecal administration of opioids
Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6615 · Cited by 491
Diagnosis and management of adrenal insufficiency
Bancos, I., Hahner, S., Tomlinson, J., & Arlt, W. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70142-1 · Cited by 467
Self-citationHypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401
Daniell, H. W. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.08.005 · Cited by 263
Rushworth, R. L., Torpy, D. J., & Falhammar, H. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1807486 · Cited by 262
Ospina, N. S., Al Nofal, A., Bancos, I., Javed, A., Benkhadra, K., Kapoor, E., Lteif, A. N., Natt, N., & Murad, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1700 · Cited by 247
Self-citationDelayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients
Bleicken, B., Ventz, M., Quinkler, M., & Hahner, S. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181db6b7a · Cited by 242
Research works printed but not linked: 1
- Rabi, 2016, Case challenge: chronic opioid use causing adrenal insufficiency, Pract Pain Manag.
Cited by
Adrenal Insufficiency in Adults: A Review
Vaidya, A., Findling, J., & Bancos, I. (2025) · JAMA · doi:10.1001/jama.2025.5485 · Cited by 75
Self-citationPrevalence of opioid-induced adrenal insufficiency in patients taking chronic opioids
Li, T., Cunningham, J. L., Gilliam, W. P., Loukianova, L., Donegan, D. M., & Bancos, I. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa499 · Cited by 51
Self-citationSecondary Adrenal Insufficiency: Recent Updates and New Directions for Diagnosis and Management
Gruber, L., & Bancos, I. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.09.011 · Cited by 45
Self-citationIatrogenic adrenal insufficiency in adults
Martin‐Grace, J., Tomkins, M., O’Reilly, M., & Sherlock, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00929-x · Cited by 40
Lee, J.-E., & Won, J. C. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0299 · Cited by 40
Metadata
- Authors
- Li, T., Donegan, D., Hooten, W. M., & Bancos, I.
- Affiliations
- St. Luke's-Roosevelt Hospital Center (US)
- Indiana University Indianapolis (US)
- Mayo Clinic (US)
- Corresponding author
- Bancos, Irina
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 26
- Issue
- 11
- Pages
- 1291-1297
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W3037305234
- Semantic Scholar
- c85f8b6dfb6cea9aadbbf0a64aec9d862e651aaa
- Cited by
- 27
- References
- 30
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 7 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 1
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Endocrine Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- long-term opioid therapy, hypothalamic-pituitary-adrenal axis suppression, glucocorticoid replacement therapy, ACTH stimulation test, ACTH, dehydroepiandrosterone sulfate, morphine milligram equivalents, opioid tapering, clinical features, case finding
- MeSH terms
- Adrenal Insufficiency, Adult, Analgesics, Opioid, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Retrospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Presentation and Outcomes of Opioid-Induced Adrenal Insufficiency. https://app.cochat.ai/papers/10.4158/ep-2020-0297
- The paper
- Li, T., Donegan, D., Hooten, W. M., & Bancos, I. (2020). Clinical Presentation and Outcomes of Opioid-Induced Adrenal Insufficiency. Endocrine Practice. https://doi.org/10.4158/ep-2020-0297
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.